Handelsavisen
prelaunch
GE
GENS.NS IT Services & Consulting

Gens.Ns

$331,40
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
28,0 %
ROE
10,1 %
Net margin
18,1 %
Debt / equity
0,22
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

GENS.NS provides IT services and consulting solutions, primarily generating revenue through service contracts and project-based engagements.

Business. GENS.NS provides IT services and consulting solutions, primarily generating revenue through service contracts and project-based engagements.

Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustryIT Services & Consulting
ActivityIT Services
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target940,00

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
940,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
50
composite score
Valuation
valuation pending
Analysts
Buy
1 analysts · indicative
Ownership
not yet wired
Profitability
10,1 %
return on equity
Quality
59
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning GENS.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,2 %+1,6 %+2,4 %
    Energy+1,2 %+5,3 %+1,4 %
    Real Estate+0,7 %+4,1 %+0,8 %
    Health Care+0,7 %−0,5 %+0,8 %
    Consumer Discretionary+0,3 %+8,7 %+0,5 %
    Information Technology · THIS SECTOR−0,3 %+6,6 %−0,1 %
    Financials−0,3 %−4,5 %−0,1 %
    Consumer Staples−1,0 %+3,0 %−0,8 %
    Utilities−1,5 %−21,2 %−1,3 %
    Industrials−1,7 %−2,3 %−1,6 %
    Communication Services

    Developing storylines

    No tracked sagas currently linked to GENS.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-07 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score50 / 100
    Composite score 0-100 · Data quality 0,59
    Data quality0,59 / 1.00

    Synthesis

    Business

    GENS.NS provides IT services and consulting solutions, primarily generating revenue through service contracts and project-based engagements.

    Classification92 %
    SectorTechnology
    Business sectorSoftware & IT Services
    IndustryIT Services & Consulting
    ActivityIT Services
    AI synthesis
    GENERATED

    GENS.NS maintains a conservative capital structure with a debt-to-equity ratio of 0.22, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.41, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the operating cash flow is negative at -528.58 million INR, which may raise concerns about the company's ability to fund operations from core business activities.

    In terms of profitability, GENS.NS reports a return on equity (ROE) of 10.12% and a return on assets (ROA) of 7.23%, both of which are strong indicators of efficient use of equity and assets to generate profit. The company's operating income of 872.09 million INR and net income of 562.23 million INR further support its profitability. These metrics suggest that GENS.NS is performing well relative to its industry peers, although specific comparisons to industry medians are not available in the provided data.

    GENS.NS's revenue is concentrated in its IT services and consulting business, with no disclosed geographic diversification in the provided data. This concentration may expose the company to risks associated with market-specific downturns or shifts in demand for IT services. The absence of detailed segment or geographic breakdowns limits the ability to assess the company's exposure to different markets or product lines.

    The company's growth trajectory is supported by a strong analyst consensus, with a mean price target of 940.00 INR and a mean recommendation of 1.00 (strong buy). However, the lack of historical revenue growth data in the provided input restricts the ability to quantify the company's growth rate or compare it to industry benchmarks. The free cash flow of 707.41 million INR indicates the company is generating positive cash from operations after capital expenditures, which can be used for reinvestment or shareholder returns.

    The risk assessment for GENS.NS highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting potential challenges in maintaining liquidity without external financing. The dilution risk is considered low, with no significant dilution potential identified in the basic shares outstanding data. The company's capital structure and liquidity position suggest that it is not currently under pressure to issue additional shares to meet financial obligations.

    Recent events and filings for GENS.NS are not detailed in the provided data, limiting the ability to assess the company's recent performance or strategic direction. The absence of specific events or disclosures means that the company's recent developments cannot be evaluated in detail.

    Key takeaways
    • GENS.NS has a strong return on equity (10.12%) and return on assets (7.23%), indicating efficient use of capital.
    • The company's debt-to-equity ratio of 0.22 suggests a conservative capital structure with limited reliance on debt.
    • Analysts have a strong buy consensus with a mean price target of 940.00 INR, reflecting positive sentiment.
    • The company's negative operating cash flow (-528.58 million INR) raises concerns about its ability to fund operations from core business activities.
    • GENS.NS's revenue is concentrated in IT services and consulting, with no disclosed geographic diversification, which may increase market-specific risks.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $331,40
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $5.56B
    Net cash
    -$1.22B
    Current ratio
    2.4
    Debt / equity
    0.2
    ROA
    7.2%
    ROE
    10.1%
    Cash conversion
    -94.0%
    CapEx / revenue
    -14.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    16,90
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-10 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate16,90
    Revenueno estimateno estimate4,4B INR
    Operating incomeno estimateno estimate989,0M INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-07-07

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy1
    Buy0
    Hold0
    Sell0
    Strong sell0
    12-month price target$940,00 · Median $940,00
    Low $940,00High $940,00
    Operating income · consensus989,0M INR
    EPS surprise
    −17,0 %
    reported vs consensus · miss
    Revenue surprise
    −28,5 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$940,00
    Mean$940,00
    Median$940,00
    High$940,00
    Spot$331,40
    +183.6 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin28,0 %Best in class
    Net Margin18,1 %Best in class
    ROE10,1 %Above median
    Capex / Rev-14,0 %Bottom quartile
    D/E0,22Below median
    Cash Conv-0,94Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • GENS.NS Market data — financials · 2026-05-28
    • Genesys International Corporation Ltd Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    GENS.NSCanonical
    — · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage